Neurohormonal Blocking Agents in the Treatment of Patients with Left Ventricular Dysfunction and Heart Failure

Ruchika Dutta; Barry H. Greenberg

doi:10.1002/9780470669402.ch4

Neurohormonal Blocking Agents in the Treatment of Patients with Left Ventricular Dysfunction and Heart Failure

Ruchika Dutta
, Barry H. Greenberg

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Original language	English
Title of host publication	Management of Heart Failure
Publisher	John Wiley and Sons
Pages	83-116
Number of pages	34
ISBN (Print)	9780470753798
DOIs	https://doi.org/10.1002/9780470669402.ch4
State	Published - Sep 14 2010

Keywords

Angiotensin receptor blockers (ARBs) - alternative mechanism of blocking
Beta-adrenergic blocking agents (beta-blockers)
Clinical trials with beta-blockers
Hypotension management - associated with beta-blocker, ACEI, or ARB use
LV remodeling improvement - with metoprolol succinate in REVERT study
Neurohormonal activation involvement - in pathogenesis and progression of heart failure
Neurohormonal blocking agents, in treatment of patients with left ventricular dysfunction and heart failure
Neurohormonal pathways and sites of action - of pharmacologic agents
Pharmacologic properties - of beta-blockers
Treatment modalities

Access to Document

10.1002/9780470669402.ch4

Cite this

@inbook{3d0ab00640794e96be4ee0355db9a13d,

title = "Neurohormonal Blocking Agents in the Treatment of Patients with Left Ventricular Dysfunction and Heart Failure",

keywords = "Angiotensin receptor blockers (ARBs) - alternative mechanism of blocking, Beta-adrenergic blocking agents (beta-blockers), Clinical trials with beta-blockers, Hypotension management - associated with beta-blocker, ACEI, or ARB use, LV remodeling improvement - with metoprolol succinate in REVERT study, Neurohormonal activation involvement - in pathogenesis and progression of heart failure, Neurohormonal blocking agents, in treatment of patients with left ventricular dysfunction and heart failure, Neurohormonal pathways and sites of action - of pharmacologic agents, Pharmacologic properties - of beta-blockers, Treatment modalities",

author = "Ruchika Dutta and Greenberg, \{Barry H.\}",

year = "2010",

month = sep,

day = "14",

doi = "10.1002/9780470669402.ch4",

language = "English",

isbn = "9780470753798",

pages = "83--116",

booktitle = "Management of Heart Failure",

publisher = "John Wiley and Sons",

}

TY - CHAP

T1 - Neurohormonal Blocking Agents in the Treatment of Patients with Left Ventricular Dysfunction and Heart Failure

AU - Dutta, Ruchika

AU - Greenberg, Barry H.

PY - 2010/9/14

Y1 - 2010/9/14

KW - Angiotensin receptor blockers (ARBs) - alternative mechanism of blocking

KW - Beta-adrenergic blocking agents (beta-blockers)

KW - Clinical trials with beta-blockers

KW - Hypotension management - associated with beta-blocker, ACEI, or ARB use

KW - LV remodeling improvement - with metoprolol succinate in REVERT study

KW - Neurohormonal activation involvement - in pathogenesis and progression of heart failure

KW - Neurohormonal blocking agents, in treatment of patients with left ventricular dysfunction and heart failure

KW - Neurohormonal pathways and sites of action - of pharmacologic agents

KW - Pharmacologic properties - of beta-blockers

KW - Treatment modalities

UR - https://www.scopus.com/pages/publications/84886207424

U2 - 10.1002/9780470669402.ch4

DO - 10.1002/9780470669402.ch4

M3 - Chapter

AN - SCOPUS:84886207424

SN - 9780470753798

SP - 83

EP - 116

BT - Management of Heart Failure

PB - John Wiley and Sons

ER -

Neurohormonal Blocking Agents in the Treatment of Patients with Left Ventricular Dysfunction and Heart Failure

Keywords

Access to Document

Other files and links

Cite this